OrthoSpin this week announced that it received FDA clearance for its second generation, robotic, digitally-enabled external fixation system for orthopedic treatments.
The G2 system makes pre-programmed adjustments automatically without patient involvement. It allows physicians to chart patient progress and immediately adjust treatment plans as needed.
“We are very excited to launch the Generation 2 OrthoSpin system,” active chairperson Assaf Dekel said in a news release. “We believe that robotic automation will revolutionize the hexapod bone deformity market and we are proud to play a part in this transformation.”
OrthoSpin’s G2 system is approved in Israel and can be used with the DePuy Synthes MaxFrame Multi-Axial Correction System.
